Long-term data show darolutamide is safe for patients with metastatic CRPC

Media coverage

• Title	Long-term data show darolutamide is safe for patients with metastatic CRPC
  Media name/outlet	Urology Times
  Country/Territory	United States
  Date	18/02/22
  URL	https://www.urologytimes.com/view/long-term-data-show-darolutamide-is-safe-for-patients-with-metastatic-crpc
  Persons	Egils Vjaters

• Title	Darolutamide Yields Positive Safety Data in mCRPC
  Media name/outlet	Cancernetwork.com
  Country/Territory	United States
  Date	18/02/22
  URL	https://www.cancernetwork.com/view/darolutamide-yields-positive-safety-data-in-mcrpc
  Persons	Egils Vjaters